Cargando…

Quinacrine Induces Nucleolar Stress in Treatment-Refractory Ovarian Cancer Cell Lines

SIMPLE SUMMARY: A high mortality rate in ovarian cancer imposes the need for improved therapy; most patients initially respond to systemic chemotherapy but later relapse with fatal treatment-refractory tumors. We previously evaluated repurposing the antimalarial agent quinacrine as an anticancer age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oien, Derek B., Ray, Upasana, Pathoulas, Christopher L., Jin, Ling, Thirusangu, Prabhu, Jung, Deokbeom, Kumka, Joseph E., Xiao, Yinan, Sarkar Bhattacharya, Sayantani, Montoya, Dennis, Chien, Jeremy, Shridhar, Viji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466834/ https://www.ncbi.nlm.nih.gov/pubmed/34572872 http://dx.doi.org/10.3390/cancers13184645

Ejemplares similares

Quinacrine-Induced Autophagy in Ovarian Cancer Triggers Cathepsin-L Mediated Lysosomal/Mitochondrial Membrane Permeabilization and Cell Death
por: Thirusangu, Prabhu, et al.
Publicado: (2021)

Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
por: Oien, Derek B., et al.
Publicado: (2021)

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses
por: Sarkar Bhattacharya, Sayantani, et al.
Publicado: (2019)

Exploiting LRRC15 as a Novel Therapeutic Target in Cancer
por: Ray, Upasana, et al.
Publicado: (2022)

Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer
por: Xiao, Yinan, et al.
Publicado: (2021)

Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer
por: Jung, DeokBeom, et al.
Publicado: (2018)

PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
por: Ray, Upasana, et al.
Publicado: (2023)

Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis
por: Ydsten, Karin A, et al.
Publicado: (2021)

Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer
por: Ray, Upasana, et al.
Publicado: (2022)

Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth
por: Khurana, Ashwani, et al.
Publicado: (2015)

Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization
por: Ray, Upasana, et al.
Publicado: (2021)

Quinacrine in the Eradication of Giardia Lamblia Infection
por: Pant, K. C., et al.
Publicado: (1942)

Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer
por: Kumar, Sanjeev, et al.
Publicado: (2019)

Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
por: Mondal, Susmita, et al.
Publicado: (2018)

Parenteral Quinacrine in Malarial Fevers
por: Basumullick, K. L., et al.
Publicado: (1947)

Treatment of Oriental Sore with Quinacrine
por: Sachdeva, Y. V.
Publicado: (1943)

Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine.
por: de Souza, P. L., et al.
Publicado: (1997)

Pharmacokinetics of quinacrine in the treatment of prion disease
por: Yung, Lotus, et al.
Publicado: (2004)

Toxic Symptoms Associated with Quinacrine Treatment
por: Nandi, D. K.
Publicado: (1947)

Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
por: Yan, Daisy, et al.
Publicado: (2020)

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine
por: Vignaux, Patricia A., et al.
Publicado: (2023)

Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
por: Chien, Jeremy, et al.
Publicado: (2013)

Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions
por: Ghaemmaghami, Sina, et al.
Publicado: (2009)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

Quinacrine, an Old Drug with Potentially usefull in the Treatment for COVID-19
por: PINEDA, BENJAMIN
Publicado: (2021)

Multimodal Investigation into the Interaction of Quinacrine with Microcavity-Supported Lipid Bilayers
por: Sarangi, Nirod Kumar, et al.
Publicado: (2022)

Endometrial abnormalities on transvaginal ultrasonography and histopathology in women after quinacrine sterilization
por: Afzal, Saira, et al.
Publicado: (2014)

Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties
por: Chumanevich, Alexander A., et al.
Publicado: (2016)

Two Cases Showing Cerebral Symptoms after Treatment with Quinacrine for Malaria
por: Berry, J. N.
Publicado: (1945)

Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020)

Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation
por: Kulkarni, Nishant S., et al.
Publicado: (2020)

Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia
por: Wu, Limei, et al.
Publicado: (2021)

Influence of quinacrine and chloroquine on the in vitro 3′-azido-3′-deoxythymidine antiretroviral effect
por: Torres, Klintsy J, et al.
Publicado: (2015)

Protective effect of quinacrine against glycerol-induced acute kidney injury in rats
por: Al Asmari, Abdulrahman K., et al.
Publicado: (2017)

Quinacrine pretreatment reduces microwave-induced neuronal damage by stabilizing the cell membrane
por: Ding, Xue-feng, et al.
Publicado: (2018)

Network-based Survival Analysis Reveals Subnetwork Signatures for Predicting Outcomes of Ovarian Cancer Treatment
por: Zhang, Wei, et al.
Publicado: (2013)

Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter
por: Ahn, Misol, et al.
Publicado: (2012)

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
por: Eriksson, A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e2jqhg46etfvh44ievbsqeuh2t